vix.ing · top · new · best · stats · spec

Doraid Alrifai

  1. Beyond chemoradiotherapy: improving treatment outcomes for patients with stage III unresectable non-small-cell lung cancer through immuno-oncology and durvalumab (Imfinzi®▼, AstraZeneca UK Limited)
    2020/12/01 by Priyanka Patel, on behalf of AstraZeneca UK Limited, Doraid Alrifai +3 · 11 citations
    Medicine · #Cancer Immunotherapy and Biomarkers #Lung Cancer Treatments and Mutations #Lung Cancer Diagnosis and Treatment